These results not only confirmed that VEGFR1+ BMDCs were recruited to the ‘primary' tumour and secondary sites, but also suggested that Id1-induced IGF2 plays an important role in activating and mobilizing VEGFR1+ BMDCs. The gene discussed is IGF2; the disease is neoplasm.